AI Verdict
Both stocks have similar AI ratings. Review detailed metrics below.
RNAZ vs RMTI Fundamental Comparison
| Metric | RNAZ | RMTI |
|---|---|---|
| Revenue | N/A | $69.3M |
| Net Income | $-21.2M | $-5.3M |
| Net Margin | N/A | -7.7% |
| ROE | -1,488.0% | -14.4% |
| ROA | -406.0% | -9.3% |
| Current Ratio | 1.60x | 3.98x |
| Debt/Equity | 1.57x | 0.24x |
| EPS | $-34.49 | $-0.15 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RNAZ vs RMTI: Frequently Asked Questions
Is RNAZ or RMTI a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), both stocks have similar ratings. RNAZ is rated STRONG SELL (88% confidence) while RMTI is rated STRONG SELL (88% confidence). This is not investment advice.
How does RNAZ compare to RMTI fundamentally?
Transcode Therapeutics, Inc. has ROE of -1,488.0% vs ROCKWELL MEDICAL, INC.'s -14.4%. Net margins are N/A vs -7.7% respectively.
Which stock pays higher dividends, RNAZ or RMTI?
RNAZ has a dividend yield of N/A or no dividend while RMTI has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RNAZ or RMTI for long term?
For long-term investing, consider that RNAZ has STRONG SELL rating with 88% confidence, while RMTI has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RNAZ vs RMTI?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RNAZ vs RMTI, both AIs rate them similarly based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.